BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Amylyx Pharmaceuticals (NASDAQ:AMLX)

1 post

Biotech NewsAmylyx (AMLX) Could Be the Biotech Underdog Set to Dominate Neurology in 2025

  • BioTech Health X
  • June 19, 2025
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is a pioneering biopharmaceutical company committed to developing novel and life-extending treatments for people…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Multikine’s 73% 5-Year Survival Rate Shocks Wall Street — Is CEL-SCI (CVM) the Next Big Winner?
  • Analysts Say Tango (TNGX) is Worth $10.43—Here’s Why It Might Go Even Higher
  • Is Prelude (PRLD) the Next Biotech Titan? Investors Are Watching this Stock Closely
  • This $1 Stock Has a $6 Price Target—Is Pyxis (PYXS) the Best Cheap Biotech Play Right Now?
  • Foghorn Therapeutics (FHTX) is Quietly Building a Biotech Empire—Here’s Why Investors Are Watching
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • June 19, 2025
    Multikine’s 73% 5-Year Survival Rate Shocks Wall Street — Is CEL-SCI (CVM) the Next Big Winner?
    • June 19, 2025
    Analysts Say Tango (TNGX) is Worth $10.43—Here’s Why It Might Go Even Higher
    • June 19, 2025
    Is Prelude (PRLD) the Next Biotech Titan? Investors Are Watching this Stock Closely
    • June 19, 2025
    This $1 Stock Has a $6 Price Target—Is Pyxis (PYXS) the Best Cheap Biotech Play Right Now?
    • June 19, 2025
    Foghorn Therapeutics (FHTX) is Quietly Building a Biotech Empire—Here’s Why Investors Are Watching
Recent Posts
  • ADC Therapeutics (ADCT): The Cancer-Fighting Biotech With a 200%+ Upside Potential
    • June 19, 2025
  • Alkermes (ALKS) Could Be the Best Neuroscience Stock to Own This Decade
    • June 19, 2025
  • Corbus (CRBP) has $149M in Cash & a Cancer Drug That Could Shock Wall Street
    • June 19, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (192)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top